313 related articles for article (PubMed ID: 25587773)
1. Blood diagnostic biomarkers for major depressive disorder using multiplex DNA methylation profiles: discovery and validation.
Numata S; Ishii K; Tajima A; Iga J; Kinoshita M; Watanabe S; Umehara H; Fuchikami M; Okada S; Boku S; Hishimoto A; Shimodera S; Imoto I; Morinobu S; Ohmori T
Epigenetics; 2015; 10(2):135-41. PubMed ID: 25587773
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation signatures of peripheral leukocytes in schizophrenia.
Kinoshita M; Numata S; Tajima A; Shimodera S; Ono S; Imamura A; Iga J; Watanabe S; Kikuchi K; Kubo H; Nakataki M; Sumitani S; Imoto I; Okazaki Y; Ohmori T
Neuromolecular Med; 2013 Mar; 15(1):95-101. PubMed ID: 22961555
[TBL] [Abstract][Full Text] [Related]
3. Investigating DNA Methylation of SHATI/NAT8L Promoter Sites in Blood of Unmedicated Patients with Major Depressive Disorder.
Miyanishi H; Uno K; Iwata M; Kikuchi Y; Yamamori H; Yasuda Y; Ohi K; Hashimoto R; Hattori K; Yoshida S; Goto YI; Sumiyoshi T; Nitta A
Biol Pharm Bull; 2020; 43(7):1067-1072. PubMed ID: 32612069
[TBL] [Abstract][Full Text] [Related]
4. Methylation of the tryptophan hydroxylase‑2 gene is associated with mRNA expression in patients with major depression with suicide attempts.
Zhang Y; Chang Z; Chen J; Ling Y; Liu X; Feng Z; Chen C; Xia M; Zhao X; Ying W; Qing X; Li G; Zhang C
Mol Med Rep; 2015 Aug; 12(2):3184-90. PubMed ID: 25955598
[TBL] [Abstract][Full Text] [Related]
5. Convergence of evidence from a methylome-wide CpG-SNP association study and GWAS of major depressive disorder.
Aberg KA; Shabalin AA; Chan RF; Zhao M; Kumar G; van Grootheest G; Clark SL; Xie LY; Milaneschi Y; Penninx BWJH; van den Oord EJCG
Transl Psychiatry; 2018 Aug; 8(1):162. PubMed ID: 30135428
[TBL] [Abstract][Full Text] [Related]
6. Integrated Analysis of Methylomic and Transcriptomic Data to Identify Potential Diagnostic Biomarkers for Major Depressive Disorder.
Xie Y; Xiao L; Chen L; Zheng Y; Zhang C; Wang G
Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33513891
[TBL] [Abstract][Full Text] [Related]
7. Parvalbumin Promoter Methylation Altered in Major Depressive Disorder.
Thaweethee-Sukjai B; Suttajit S; Thanoi S; Dalton CF; Reynolds GP; Nudmamud-Thanoi S
Int J Med Sci; 2019; 16(9):1207-1214. PubMed ID: 31588185
[No Abstract] [Full Text] [Related]
8. Longitudinal multi-level biomarker analysis of BDNF in major depression and bipolar disorder.
Schröter K; Brum M; Brunkhorst-Kanaan N; Tole F; Ziegler C; Domschke K; Reif A; Kittel-Schneider S
Eur Arch Psychiatry Clin Neurosci; 2020 Mar; 270(2):169-181. PubMed ID: 30929061
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide profiling of DNA methylome and transcriptome in peripheral blood monocytes for major depression: A Monozygotic Discordant Twin Study.
Zhu Y; Strachan E; Fowler E; Bacus T; Roy-Byrne P; Zhao J
Transl Psychiatry; 2019 Sep; 9(1):215. PubMed ID: 31477685
[TBL] [Abstract][Full Text] [Related]
10. DNA hypomethylation of Synapsin II CpG islands associates with increased gene expression in bipolar disorder and major depression.
Cruceanu C; Kutsarova E; Chen ES; Checknita DR; Nagy C; Lopez JP; Alda M; Rouleau GA; Turecki G
BMC Psychiatry; 2016 Aug; 16(1):286. PubMed ID: 27515700
[TBL] [Abstract][Full Text] [Related]
11. Biological tests for major depressive disorder that involve leukocyte gene expression assays.
Watanabe SY; Iga J; Ishii K; Numata S; Shimodera S; Fujita H; Ohmori T
J Psychiatr Res; 2015; 66-67():1-6. PubMed ID: 25943949
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide DNA methylation scan in major depressive disorder.
Sabunciyan S; Aryee MJ; Irizarry RA; Rongione M; Webster MJ; Kaufman WE; Murakami P; Lessard A; Yolken RH; Feinberg AP; Potash JB;
PLoS One; 2012; 7(4):e34451. PubMed ID: 22511943
[TBL] [Abstract][Full Text] [Related]
13. Glucocorticoid receptor gene (NR3C1) promoter is hypermethylated in Thai females with major depressive disorder.
Nantharat M; Wanitchanon T; Amesbutr M; Tammachote R; Praphanphoj V
Genet Mol Res; 2015 Dec; 14(4):19071-9. PubMed ID: 26782558
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic Response to Paroxetine in Major Depressive Disorder Predicted by DNA Methylation.
Takeuchi N; Nonen S; Kato M; Wakeno M; Takekita Y; Kinoshita T; Kugawa F
Neuropsychobiology; 2017; 75(2):81-88. PubMed ID: 29131015
[TBL] [Abstract][Full Text] [Related]
15. Intra-Monozygotic Twin Pair Discordance and Longitudinal Variation of Whole-Genome Scale DNA Methylation in Adults.
Zhang N; Zhao S; Zhang SH; Chen J; Lu D; Shen M; Li C
PLoS One; 2015; 10(8):e0135022. PubMed ID: 26248206
[TBL] [Abstract][Full Text] [Related]
16. Integrated genome-wide methylation and expression analyses reveal functional predictors of response to antidepressants.
Ju C; Fiori LM; Belzeaux R; Theroux JF; Chen GG; Aouabed Z; Blier P; Farzan F; Frey BN; Giacobbe P; Lam RW; Leri F; MacQueen GM; Milev R; Müller DJ; Parikh SV; Rotzinger S; Soares CN; Uher R; Li Q; Foster JA; Kennedy SH; Turecki G
Transl Psychiatry; 2019 Oct; 9(1):254. PubMed ID: 31594917
[TBL] [Abstract][Full Text] [Related]
17. Altered DNA methylation of glucose transporter 1 and glucose transporter 4 in patients with major depressive disorder.
Kahl KG; Georgi K; Bleich S; Muschler M; Hillemacher T; Hilfiker-Kleinert D; Schweiger U; Ding X; Kotsiari A; Frieling H
J Psychiatr Res; 2016 May; 76():66-73. PubMed ID: 26919485
[TBL] [Abstract][Full Text] [Related]
18. A haplotype of glycogen synthase kinase 3β is associated with early onset of unipolar major depression.
Saus E; Soria V; Escaramís G; Crespo JM; Valero J; Gutiérrez-Zotes A; Martorell L; Vilella E; Menchón JM; Estivill X; Gratacòs M; Urretavizcaya M
Genes Brain Behav; 2010 Oct; 9(7):799-807. PubMed ID: 20618448
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide methylation profiling and a multiplex construction for the identification of body fluids using epigenetic markers.
Lee HY; An JH; Jung SE; Oh YN; Lee EY; Choi A; Yang WI; Shin KJ
Forensic Sci Int Genet; 2015 Jul; 17():17-24. PubMed ID: 25796047
[TBL] [Abstract][Full Text] [Related]
20. Aberrant DNA methylation of blood in schizophrenia by adjusting for estimated cellular proportions.
Kinoshita M; Numata S; Tajima A; Ohi K; Hashimoto R; Shimodera S; Imoto I; Takeda M; Ohmori T
Neuromolecular Med; 2014 Dec; 16(4):697-703. PubMed ID: 25052007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
